Aytu BioPharma Inc. share price logo

Aytu BioPharma Inc.

NASDAQ: AYTU

Small Cap

$2.11

+0.03

(+1.44%)

Live

as on

Aytu BioPharma Inc. Stock Performance

as on June 18, 2026 at 5:39 am IST

  • Day's Low

    Day's High

    $2.10
    $2.17
    downward going graph

    0.47%

    Downside

    2.84%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.65
    $3.07
    downward going graph

    21.80%

    Downside

    45.26%

    Upside

    downward going graph

Aytu BioPharma Inc. share price movements today

Previous Close
$2.08
Open
$2.10
Volume
57.7K
Day's Low - High
$2.10 - $2.17
52 Week Low - High
$1.65 - $3.07

Aytu BioPharma Inc. Historical Returns

1 Month Return
-5.02 %
3 Month Return
-19.69 %
1 Year Return
+ 5.58 %
3 Year Return
+ 14.29 %
5 Year Return
-97.91 %

Aytu BioPharma Inc. Stock Fundamentals & Key Indicators

Check Aytu BioPharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$22.5M

EPS (TTM)

-1.135

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-2.6M

Revenue (TTM)

56.6M

Profit Margin

-60.17%

Return On Equity TTM

-97.42%

Aytu BioPharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aytu BioPharma Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Aytu BioPharma Inc. image
Aytu BioPharma Inc.
BUY$22.5M-97.91%NA-60.17%NA
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$23.3B200.57%20.2840.62%NA
Viatris Inc. image
Viatris Inc.
HOLD$19.0B9.34%NA-2.04%2.91%
Haleon plc (ADR) image
Haleon plc (ADR)
BUY$40.0BNA18.1415.11%2.13%
ZOETIS INC. image
ZOETIS INC.
BUY$33.5B-57.45%13.1128.04%2.55%
See all

Stock Returns calculator for Aytu BioPharma Inc. Stock including INR - Dollar returns

The Aytu BioPharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Aytu BioPharma Inc. investment value today

Current value as on today

₹1,17,260

Returns

₹17,260

(+17.26%)

Returns from Aytu BioPharma Inc. Stock

₹7,107 (+7.11%)

Dollar Impact

₹10,153 (+10.15%)

Analyst Recommendation on Aytu BioPharma Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Aytu BioPharma Inc.. Average target price of $9.5

Aytu BioPharma Inc. Share Price Target

Get share price movements and forecasts by analysts on Aytu BioPharma Inc..

What analysts predicted

77.79%UPSIDE

Target Price

$9.5

Current Price

$2.11

Analyzed by

7 Analysts

Target

$9.50

Aytu BioPharma Inc. target price $9.5, a slight upside of 77.79% compared to current price of $2.11. According to 7 analysts rating.

Indian Investors' Interest in Aytu BioPharma Inc. Stock

Search interest for Aytu BioPharma Inc. Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

Aytu BioPharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
18
14
17
16
16
18
15
13
15
12
Gross Profit
14
10
11
11
10
12
10
9
9
6
Operating Income
3
-1
-3
0
-1
2
-7
-1
-1
-4
EBITDA
4
1
-5
3
2
6
-17
3
-9
-4
Interest Expense
1
1
4
0
1
0
0
0
0
0
Depreciation
2
1
1
1
1
1
1
0
0
1
Income Before Tax
1
-1
-3
1
0
3
-19
1
-10
-5
Income Tax Expense
0
0
0
0
0
0
0
-
-
0
Net Income
0
-2
-4
1
0
3
-19
1
-10
-5
Net Profit Margin
-1.17%
-20.58%
-25.68%
8.89%
4.86%
21.65%
-130.94%
14.15%
-69.79%
-45.27%

Aytu BioPharma Inc. Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
2
3
3
7
27
65
96
107
65
66
Gross Profit
1
1
1
5
19
29
50
66
49
45
Operating Income
-21
-20
-19
-16
-21
-58
-109
-17
-1
-7
EBITDA
-21
-18
-15
-14
-12
-29
-27
-3
1
-4
Interest Expense
5
2
0
-
-
37
147
4
4
3
Depreciation
-
4
2
2
6
9
10
4
8
5
Income Before Tax
-28
-22
-10
-27
-13
-58
-108
-17
-10
-13
Income Tax Expense
8
1
-2
20
-9
0
0
0
2
0
Net Income
-28
-22
-10
-47
-13
-58
-108
-17
-15
-13
Net Profit Margin
-1099.73%
-698.67%
-278.36%
-644.33%
-49.29%
-88.81%
-112.53%
-15.88%
-24.31%
-20.43%

Aytu BioPharma Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-2
-4
1
0
3
-19
1
-10
-5
Operating Cash Flow
0
0
-1
2
-6
2
0
3
-4
Investing Cash Flow
0
0
0
0
0
-3
-
0
-
Financing Cash Flow
0
1
0
-2
4
12
2
-6
0
Change in Cash
0
0
0
0
-2
12
1
-2
-3

Aytu BioPharma Inc. Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-22
-10
-27
-13
-58
-108
-17
-15
-13
Operating Cash Flow
-13
-15
-13
-28
-25
-28
-5
-1
-1
Investing Cash Flow
-3
0
-1
-5
-2
-3
0
0
-2
Financing Cash Flow
10
22
19
71
30
1
8
-1
15
Change in Cash
-7
6
4
37
1
-30
3
-2
10

Global Institutional Holdings in Aytu BioPharma Inc.

Funds
Holdings
Vanguard Fiduciary Trust Co
0.44%
Dimensional Fund Advisors, Inc.
0.41%
Citadel Advisors Llc
0.34%
JAFFETILCHIN INVESTMENT PARTNERS, LLC
0.16%
DRW Securities, LLC
0.27%
See all

Insights on Aytu BioPharma Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -10.58M → -5.61M (in $), with an average increase of 88.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 138.1% return, outperforming this stock by 123.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation Common Stock has given 91.1% return, outperforming this stock by 85.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 15.16M → 12.41M (in $), with an average decrease of 18.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AYTU stock has moved down by -7.1%

About Aytu BioPharma Inc.

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
OrganisationAytu BioPharma Inc.
HeadquartersDenver Corporate Center III, Denver, CO, United States, 80237
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Joshua R. Disbrow
E-voting on sharesClick here to vote

Key Management of Aytu BioPharma Inc.

Name

Title

Mr. Joshua R. Disbrow

CEO & Director

Mr. Ryan J. Selhorn CPA

CFO, Corporate Secretary & Treasurer

Mr. Jarrett T. Disbrow Ph.D.

Chief Business Officer

Mr. Greg Pyszczymuka

Chief Commercial Officer

Ms. Margaret Cabano

Vice President of Operations

Dr. Gerwin Westfield Ph.D.

Senior Vice President of Scientific Affairs

FAQs

What is Aytu BioPharma Inc. share price today?

Aytu BioPharma Inc. share price today is $2.11 as on . Aytu BioPharma Inc. share today touched a day high of $2.17 and a low of $2.1.

What is the 52 week high and 52 week low for Aytu BioPharma Inc. share?

Aytu BioPharma Inc. share touched a 52 week high of $3.07 on and a 52 week low of $1.65 on . Aytu BioPharma Inc. stock price today i.e. is trending at $2.11,which is 31.16% down from its 52 week high and 27.87% up from its 52 week low.

What is Aytu BioPharma Inc.'s market capitalisation today?

Aytu BioPharma Inc. market capitalisation is $0.00T as on .

How to invest in Aytu BioPharma Inc. Stock (AYTU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aytu BioPharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aytu BioPharma Inc. Shares that will get you 0.7109 shares as per Aytu BioPharma Inc. share price of $2.11 per share as on June 18, 2026 at 12:09 am IST.

What is the minimum amount required to buy Aytu BioPharma Inc. Stock (AYTU) from India?

Indian investors can start investing in Aytu BioPharma Inc. (AYTU) shares with as little as ₹94.5 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.00 in Aytu BioPharma Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Aytu BioPharma Inc. share’s latest price of $2.11 as on June 18, 2026 at 12:09 am IST, you will get 4.7393 shares of Aytu BioPharma Inc.. Learn more about fractional shares .

What are the returns that Aytu BioPharma Inc. has given to Indian investors in the last 5 years?

Aytu BioPharma Inc. stock has given -97.91% share price returns and 27.67% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?